The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: a systematic analysis of the Global Burden of Disease Study 2019

被引:65
作者
Ye, Junjun [1 ,2 ]
Wu, Yixi [1 ,2 ]
Yang, Shuhui [3 ]
Zhu, Dan [3 ]
Chen, Fengwu [3 ]
Chen, Jingxian [2 ,4 ]
Ji, Xiaoxia [3 ]
Hou, Kaijian [4 ,5 ]
机构
[1] Shantou Univ, Dept Endocrine & Metab Dis, Affiliated Hosp 1, Med Coll, Shantou, Peoples R China
[2] Shantou Univ, Med Coll, Shantou, Guangdong, Peoples R China
[3] Shantou Cent Hosp, Dept Endocrine & Metab Dis, Shantou, Guangdong, Peoples R China
[4] Shantou Univ, Longhu Hosp, Dept Endocrine & Metab Dis, Affiliated Hosp 1,Med Coll, Shantou, Peoples R China
[5] Shantou Univ, Sch Publ Hlth, Shantou, Peoples R China
关键词
type 2 diabetes mellitus; epidemiology; global burden of disease; trend; forecast; GLYCEMIC CONTROL; RISK; MANAGEMENT; PATHOPHYSIOLOGY; COMPLICATIONS; EPIDEMIOLOGY; PREVALENCE; TRENDS;
D O I
10.3389/fendo.2023.1192629
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimTo report the global, regional, and national burden of type 2 diabetes mellitus (T2DM) in 2019, assess its trends in the past, and forecast its trends in the future. MethodsThe main data source was the Global Burden of Disease 2019 database. We assessed the changes in T2DM burden from 1990 to 2019 with joinpoint regression analysis. Age-period-cohort analysis was used to forecast the T2DM incidence and mortality rate from 2020 to 2034. ResultsThe burden of T2DM has increased from 1990 to 2019 generally. The low-middle socio-demographic index (SDI) region had the highest increase in age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized disability-adjusted life years (ASDR) due to T2DM. Nationally, the increase in ASIR (r=0.151, p=0.046) and the decrease in ASMR (r=0.355, p<0.001) were positively correlated with SDIs. In 2019, the global ASIR, ASPR, ASMR, ASDR due to T2DM were 259.9 (95% UI 240.3-281.4), 5282.9 (95% UI 4853.6-5752.1), 18.5 (95% UI 17.2-19.7), and 801.5 (95% UI 55477000-79005200) per 100,000 population, respectively. Additionally, the ASIR (r=0.153, p=0.030) and ASPR (r=0.159, p=0.024) of T2DM were positively correlated with SDIs, while ASMR (r=-0.226, p=0.001) and ASDR (r=-0.171, p=0.015) due to T2DM were negatively correlated with SDIs. The ASIR was estimated to increase to 284.42, and ASMR was estimated to increase to 19.1 from 2030 to 2034, per 100,000 population. ConclusionGlobally, the burden of T2DM has increased in the past and was forecast to continue increasing. Greater investment in T2DM prevention is needed.
引用
收藏
页数:12
相关论文
共 44 条
[31]   Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes Comment [J].
Sathish, Thirunavukkarasu ;
Tapp, Robyn J. ;
Cooper, Mark E. ;
Zimmet, Paul .
DIABETES & METABOLISM, 2021, 47 (02)
[32]   Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes [J].
Su, Yu ;
Zhang, Shuo ;
Wu, Zezhen ;
Liu, Weiting ;
Chen, Jingxian ;
Deng, Feiying ;
Chen, Fengwu ;
Zhu, Dan ;
Hou, Kaijian .
FRONTIERS IN ENDOCRINOLOGY, 2023, 14
[33]   Excess Mortality among Persons with Type 2 Diabetes [J].
Tancredi, Mauro ;
Rosengren, Annika ;
Svensson, Ann-Marie ;
Kosiborod, Mikhail ;
Pivodic, Aldina ;
Gudbjornsdottir, Soffia ;
Wedel, Hans ;
Clements, Mark ;
Dahlqvist, Sofia ;
Lind, Marcus .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (18) :1720-1732
[34]   Overview of trends in cardiovascular and diabetes risk factors in Fiji [J].
Taylor, R. ;
Lin, S. ;
Linhart, C. ;
Morrell, S. .
ANNALS OF HUMAN BIOLOGY, 2018, 45 (03) :188-201
[35]   An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective [J].
Tinajero, Maria G. ;
Malik, Vasanti S. .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2021, 50 (03) :337-355
[36]   Global prevalence and trends in hypertension and type 2 diabetes mellitus among slum residents: a systematic review and meta-analysis [J].
Uthman, Olalekan Abdulrahman ;
Ayorinde, Abimbola ;
Oyebode, Oyinlola ;
Sartori, Jo ;
Gill, Paramjit ;
Lilford, R. J. .
BMJ OPEN, 2022, 12 (02)
[37]   Advancement of Traditional Chinese Medicine in Regulation of Intestinal Flora: Mechanism-based Role in Disease Management [J].
Wu, Zezhen ;
Chen, Yongru ;
Zhu, Dan ;
Zheng, Yingmiao ;
Ali, Khan Barkat ;
Hou, Kaijian .
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2022, 17 (02) :136-144
[38]   Economic Costs of Diabetes in the US in 2017 [J].
Yang, Wenya ;
Dall, Timothy M. ;
Beronjia, Kaleigh ;
Lin, Janice ;
Semilla, April P. ;
Chakrabarti, Ritashree ;
Hogan, Paul F. .
DIABETES CARE, 2018, 41 (05) :917-928
[39]   Measuring the global, regional, and national burden of type 2 diabetes and the attributable risk factors in all 194 countries [J].
Yu, Mei ;
Zhan, Xiaoqing ;
Yang, Zhenxing ;
Huang, Yongmin .
JOURNAL OF DIABETES, 2021, 13 (08) :613-639
[40]   Current lifestyle factors that increase risk of T2DM in China [J].
Zhang, N. ;
Du, S. M. ;
Ma, G. S. .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2017, 71 (07) :832-838